Position
Chief Commercial Officer
Company
Genetix Biotherapeutics
SomervilleBiotechnologyHealth CareGeneticsTherapeuticsDescription
Genetix Biotherapeutics Inc. has appointed Meredith Manning as Chief Commercial Officer. She will be responsible for leading the commercial strategy and execution of the company's gene addition cell therapies.
Quick answer
Genetix Biotherapeutics Appoints Meredith Manning as Chief Commercial Officer (October 19, 2026). Genetix Biotherapeutics is based in Somerville, Massachusetts, United States.
- Who is the new Chief Commercial Officer at Genetix Biotherapeutics?
- Genetix Biotherapeutics named Meredith Manning Chief Commercial Officer, announced October 19, 2026.
- What did Genetix Biotherapeutics announce on October 19, 2026?
- Genetix Biotherapeutics Inc. has appointed Meredith Manning as Chief Commercial Officer. She will be responsible for leading the commercial strategy and execution of the company's gene addition cell therapies.
- What does Genetix Biotherapeutics do?
- Genetix Biotherapeutics Inc. is the commercial leader in genetic medicine for rare diseases, particularly in hematology.
- Where is Genetix Biotherapeutics based?
- Genetix Biotherapeutics is based in Somerville, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Crispr Therapeutics (October 19, 2026), BioMarin Pharmaceutical (October 5, 2026), MeiraGTx Holdings plc (September 23, 2026) and Transcenta Therapeutics (October 19, 2026) also announced leadership changes within 45 days of Genetix Biotherapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Genetics and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- CRISPR Therapeutics Appoints Andrew J. Silver as Chief Financial Officer (October 19, 2026)
- BioMarin Appoints Cara Bauer as Executive Vice President, Chief People Officer (October 5, 2026)
- MeiraGTx Appoints Alan M. Sebulsky as Class I Director (September 23, 2026)
- Transcenta Therapeutics Appoints Jennie Ma as Chief Financial Officer (October 19, 2026)
- Tempest Therapeutics Appoints John Frederick as Class III Director (October 19, 2026)
- CytoDyn Inc. Appoints Robert E. Hoffman as CEO (October 19, 2026)
Who to call at Genetix Biotherapeutics, and when
A new leader at Genetix Biotherapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Genetix Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genetix Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genetix Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genetix Biotherapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Genetix Biotherapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.